Total Payments
$3,221
2022 Payments
$97.41
Companies
39
Transactions
196
Medicare Patients
664
Medicare Billing
$60,324
Payment Breakdown by Category
Food & Beverage$3,183 (98.8%)
Other$28.44 (0.9%)
Education$9.69 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,183 | 193 | 98.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $28.44 | 2 | 0.9% |
| Education | $9.69 | 1 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. | $512.47 | 24 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $384.52 | 27 | $0 (2020) |
| Biogen, Inc. | $322.86 | 17 | $0 (2020) |
| UCB, Inc. | $208.62 | 11 | $0 (2019) |
| AbbVie, Inc. | $199.61 | 11 | $0 (2019) |
| Allergan, Inc. | $194.39 | 15 | $0 (2020) |
| GENZYME CORPORATION | $184.66 | 11 | $0 (2020) |
| Lundbeck LLC | $135.29 | 9 | $0 (2019) |
| Sunovion Pharmaceuticals Inc. | $119.55 | 9 | $0 (2019) |
| Amneal Pharmaceuticals LLC | $102.10 | 7 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $97.41 | 6 | Amneal Pharmaceuticals LLC ($71.52) |
| 2021 | $47.78 | 3 | Amneal Pharmaceuticals LLC ($30.58) |
| 2020 | $166.64 | 12 | Novartis Pharmaceuticals Corporation ($32.68) |
| 2019 | $1,057 | 64 | Biogen, Inc. ($216.07) |
| 2018 | $681.29 | 45 | Novartis Pharmaceuticals Corporation ($155.38) |
| 2017 | $1,170 | 66 | Teva Pharmaceuticals USA, Inc. ($400.85) |
All Payment Transactions
196 individual payment records from CMS Open Payments — Page 3 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/10/2019 | Akcea Therapeutics, Inc. | TEGSEDI (Drug) | Food and Beverage | In-kind items and services | $11.46 | General |
| Category: NEUROLOGY | ||||||
| 06/04/2019 | GENZYME CORPORATION | AUBAGIO (Drug) | Food and Beverage | In-kind items and services | $20.05 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
| 06/03/2019 | GENZYME CORPORATION | LEMTRADA (Drug) | Food and Beverage | In-kind items and services | $18.21 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
| 05/29/2019 | EMD Serono, Inc. | Mavenclad (Biological) | Food and Beverage | In-kind items and services | $11.96 | General |
| Category: Neurology | ||||||
| 05/22/2019 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $14.65 | General |
| Category: Neurology | ||||||
| 05/20/2019 | Biogen, Inc. | TECFIDERA (Drug) | Food and Beverage | In-kind items and services | $16.65 | General |
| Category: NEUROLOGY | ||||||
| 05/20/2019 | Biogen, Inc. | TECFIDERA (Drug) | Food and Beverage | In-kind items and services | $0.18 | General |
| Category: NEUROLOGY | ||||||
| 04/25/2019 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $15.16 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 04/22/2019 | Novartis Pharmaceuticals Corporation | MAYZENT (Drug) | Food and Beverage | In-kind items and services | $17.90 | General |
| Category: NEUROSCIENCE | ||||||
| 04/19/2019 | GE HEALTHCARE | — | Food and Beverage | Cash or cash equivalent | $18.73 | General |
| 04/17/2019 | Sunovion Pharmaceuticals Inc. | APTIOM (Drug) | Food and Beverage | In-kind items and services | $11.02 | General |
| Category: CNS | ||||||
| 04/05/2019 | GENZYME CORPORATION | AUBAGIO (Drug), LEMTRADA | Food and Beverage | In-kind items and services | $13.24 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
| 04/04/2019 | EMD Serono, Inc. | Mavenclad (Biological) | Food and Beverage | In-kind items and services | $17.40 | General |
| Category: Neurology | ||||||
| 04/03/2019 | Lundbeck LLC | NORTHERA (Drug) | Food and Beverage | Cash or cash equivalent | $16.27 | General |
| Category: NEUROLOGY | ||||||
| 04/02/2019 | Novartis Pharmaceuticals Corporation | GILENYA (Drug) | Food and Beverage | In-kind items and services | $12.82 | General |
| Category: NEUROSCIENCE | ||||||
| 03/19/2019 | Lundbeck LLC | NORTHERA (Drug) | Food and Beverage | Cash or cash equivalent | $17.38 | General |
| Category: NEUROLOGY | ||||||
| 03/11/2019 | AQUESTIVE THERAPEUTICS, INC. | SYMPAZAN (Drug) | Food and Beverage | In-kind items and services | $14.66 | General |
| Category: Neurology | ||||||
| 03/07/2019 | EISAI INC. | Banzel (Drug) | Food and Beverage | Cash or cash equivalent | $17.63 | General |
| Category: Neurology | ||||||
| 03/07/2019 | Novartis Pharmaceuticals Corporation | AIMOVIG (Biological) | Food and Beverage | In-kind items and services | $15.27 | General |
| Category: NEUROSCIENCE | ||||||
| 03/05/2019 | Teva Pharmaceuticals USA, Inc. | AJOVY (Drug) | Food and Beverage | In-kind items and services | $13.17 | General |
| Category: Central Nervous System | ||||||
| 03/04/2019 | Vertical Pharmaceuticals, LLC | OSMOLEX ER (Drug) | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: NONCOMPETITIVE N-METHYL-D-ASPARTATE NMDA RECEPTOR ANTAGONIST | ||||||
| 02/27/2019 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $13.83 | General |
| Category: Neurology | ||||||
| 02/25/2019 | GENZYME CORPORATION | POMPE - DISEASE (Drug) | Food and Beverage | In-kind items and services | $23.41 | General |
| 02/05/2019 | Sunovion Pharmaceuticals Inc. | APTIOM (Drug) | Food and Beverage | In-kind items and services | $17.70 | General |
| Category: CNS | ||||||
| 01/30/2019 | Supernus Pharmaceuticals, Inc. | OXTELLAR XR (Drug) | Food and Beverage | Cash or cash equivalent | $10.91 | General |
| Category: AED | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 5 | 226 | 269 | $83,192 | $22,650 |
| 2021 | 6 | 207 | 246 | $72,802 | $20,315 |
| 2020 | 4 | 231 | 282 | $72,576 | $17,360 |
Total Patients
664
Total Services
797
Medicare Billing
$60,324
Procedure Codes
15
All Medicare Procedures & Services
15 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 78 | 112 | $34,048 | $9,891 | 29.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 32 | 32 | $15,104 | $3,820 | 25.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 51 | 51 | $15,606 | $3,649 | 23.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 51 | 58 | $11,890 | $3,131 | 26.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 14 | 16 | $6,544 | $2,158 | 33.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 76 | 110 | $33,440 | $9,450 | 28.3% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 49 | 49 | $14,994 | $3,934 | 26.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 39 | 44 | $9,020 | $2,475 | 27.4% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 15 | 15 | $7,080 | $1,979 | 27.9% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 12 | 12 | $4,908 | $1,561 | 31.8% |
| 99202 | New patient outpatient visit, total time 15-29 minutes | Office | 2021 | 16 | 16 | $3,360 | $915.77 | 27.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 93 | 118 | $35,872 | $8,035 | 22.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 78 | 104 | $21,320 | $5,270 | 24.7% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 29 | 29 | $8,874 | $2,243 | 25.3% |
| 99202 | New patient office or other outpatient visit, typically 20 minutes | Office | 2020 | 31 | 31 | $6,510 | $1,811 | 27.8% |
About Dr. John Feibel, M.D
Dr. John Feibel, M.D is a Neurology healthcare provider based in Cincinnati, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1033227780.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Feibel, M.D has received a total of $3,221 in payments from pharmaceutical and medical device companies, with $97.41 received in 2022. These payments were reported across 196 transactions from 39 companies. The most common payment nature is "Food and Beverage" ($3,183).
As a Medicare-enrolled provider, Feibel has provided services to 664 Medicare beneficiaries, totaling 797 services with total Medicare billing of $60,324. Data is available for 3 years (2020–2022), covering 15 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Other Specialties Neurology
- Location Cincinnati, OH
- Active Since 08/25/2006
- Last Updated 08/01/2016
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1033227780
Products in Payments
- COPAXONE (Drug) $319.68
- Briviact (Drug) $208.62
- GILENYA (Drug) $194.65
- APTIOM (Drug) $119.55
- SD809-TD (Drug) $105.05
- Duopa (Drug) $104.56
- TECFIDERA (Drug) $102.35
- RYTARY (Drug) $102.10
- Zinbryta (Biological) $95.05
- AUBAGIO (Drug) $92.11
- AIMOVIG (Biological) $91.67
- BOTOX-NEUROLOGY (Drug) $87.46
- NUPLAZID (Drug) $86.87
- TYSABRI (Biological) $86.42
- NORTHERA (Drug) $74.51
- AJOVY (Drug) $61.26
- ONFI (Drug) $60.78
- Mavenclad (Biological) $56.23
- POMPE - DISEASE (Drug) $54.83
- MAYZENT (Drug) $53.32
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Cincinnati
Aram Zabeti, M.d, M.D
Neurology — Payments: $1.5M
Neurology $1.5M
Brian Moseley, Md, MD
Neurology — Payments: $700,525
Neurology $700,525
Dr. Hope O'brien, Md, MD
Neurology — Payments: $530,605
Neurology $530,605
Alberto Espay, Md, MD
Neurology — Payments: $448,360
Neurology $448,360
Mrs. Susan Hibbs, Md, MD
Neurology — Payments: $255,533
Neurology $255,533
Zainab Contractor, Md, MD
Neurology — Payments: $212,716
Neurology $212,716